Newsroom
Sorted by: Latest
-
Dropbox Announces Third Quarter 2026 Results
SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Dropbox, Inc. (NASDAQ: DBX), today announced financial results for its third quarter ended September 30, 2026. “Q3 was another beat-and-raise quarter, with revenue growth excluding FormSwift and non-GAAP operating margin both ahead of our guidance, marking our fifth consecutive quarter of year-over-year revenue growth excluding FormSwift,” said Ashraf Alkarmi, co-Chief Executive Officer of Dropbox. “We’re executing on our strategy to become the trusted, i...
-
Janux Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today reported financial results for the quarter ended September 30, 2026, and provided a business update. “During the third quarter, we continued to execute across our clinical portfolio, including dosing the first patient in the Phase 1 study of JANX013 in combination with JANX007,” said David Campbell, Ph.D., President a...
-
Cardlytics Reports Third Quarter 2026 Financial Results and Provides Fourth Quarter Outlook
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform, today announced financial results for the third quarter ended September 30, 2026. "Our third quarter results came in below expectations,” said Amit Gupta, CEO of Cardlytics. “However, we remain encouraged by the progress towards our priorities. We are building supply by adding new CRP partners and continuing to grow our advertising base." "We are running a leaner business, with lower costs, and a higher...
-
Smith Micro Schedules Teleconference to Announce Third Quarter 2026 Financial Results
PITTSBURGH--(BUSINESS WIRE)--Smith Micro Software, Inc. (NASDAQ: SMSI) announced that it will report its third quarter 2026 financial results following the close of regular trading on Thursday, November 12, 2026. The news release will be followed by a teleconference available to all interested parties at 4:30 pm ET / 1:30 pm PT. The Smith Micro third quarter conference call may be accessed as follows: Date and Time: Thursday, November 12, 2026 at 4:30 pm ET / 1:30 pm PT News Release: Available...
-
Perdoceo Education Corporation Reports Third Quarter and Year to Date 2026 Results
SCHAUMBURG, Ill.--(BUSINESS WIRE)--PERDOCEO EDUCATION CORPORATION REPORTS THIRD QUARTER AND YEAR TO DATE 2026 RESULTS...
-
BILL Reports First Quarter Fiscal Year 2027 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--BILL (NYSE: BILL), the intelligent finance platform trusted by nearly half a million businesses to manage, move, and maximize their money, today announced financial results for the first fiscal quarter ended September 30, 2026. “AI is changing what’s possible for us, and it shows in our product velocity: five new launches this quarter, and a Visa pilot built in four weeks,” said René Lacerte, BILL CEO and Founder. “We’re well positioned to serve the millions o...
-
Consensus Cloud Solutions, Inc. Reports Third Quarter 2026 Results; Releases Q4 2026 Guidance; Narrows Full Year 2026 Revenue and Adjusted EBITDA Guidance; Raises Full Year 2026 Adjusted Earnings Per Diluted Share Guidance
LOS ANGELES--(BUSINESS WIRE)--Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) today reported financial results for the third quarter of 2026. “Our Q3 achievements continued the momentum of the past few quarters. Our corporate channel exceeded 9% revenue growth for the second straight quarter. We also experienced sustained improvement in the SoHo channel within the range of our expectations. In addition, we were able to repurchase approximately 550,000 shares of our common stock during the quarte...
-
Verastem Oncology Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today reported financial results for the third quarter ended September 30, 2026, and highlighted recent business progress. “During the third quarter, we made significant progress with VS-7375, our potential best-in-class oral KRAS G12D (ON/OFF) inhibitor. Our first U.S. clinical data established a new monotherapy efficacy...
-
Neighborhood Intelligence Reports Core E-Commerce Growth of 9%, Led by 75% Growth at Overstock.com; Total Company Revenue Increases 98% Driven by Acquisitions
NASHVILLE, Tenn.--(BUSINESS WIRE)--Neighborhood Intelligence, Inc. (NASDAQ:NXH), formerly Bed Bath & Beyond, Inc., today reported third quarter 2026 revenue of $509 million, an increase of 98% year over year, primarily driven by the acquisitions of Kirkland’s and The Container Store. Core e-commerce revenue increased approximately 9%, led by 75% year-over-year growth at Overstock.com. Gross profit was $173 million, representing a reported gross margin of approximately 34%. The quarter inclu...
-
Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 2,010 shares of the Company’s common stock to one new employee (the “Inducement Grant”) on November 3, 2026 (the “Grant Date”). The Induceme...